VYCOR MEDICAL, INC. Operating Lease Right-of-Use Assets
VYCOR MEDICAL, INC. (VYCO) had Operating Lease Right-of-Use Assets of $30.15 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-14
- 2026-06-30: Operating Lease, Right-of-Use Asset $30.15K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $42.80K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $55.28K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $67.61K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $30.15K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $42.80K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $55.28K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $67.61K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $79.79K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $91.82K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $103.70K 10-K · filed 2026-03-31 |
| 2024-09-30 | $115.44K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $127.04K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $138.49K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $149.80K 10-K · filed 2025-04-15 |
| 2023-09-30 | $160.98K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $8.27K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $20.54K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $32.65K 10-K · filed 2024-04-16 |
| 2022-09-30 | $44.60K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $56.40K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $68.05K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $79.56K 10-K · filed 2023-04-14 |
| 2021-09-30 | $90.92K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $102.15K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $113.23K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $124.18K 10-K · filed 2022-04-13 |
| 2020-09-30 | $135.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $145.69K 10-Q · filed 2020-08-17 |
| 2020-03-31 | $156.25K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $31.66K 10-K · filed 2021-03-31 |
| 2019-09-30 | $43.59K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $54.30K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $19.14M 10-Q · filed 2019-05-13 |